ANIK Earnings Anika Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.37 | 2026-04-30 | 10-Q |
| FY 2025 | 2025-12-31 | -0.76 | 2026-03-03 | 10-K |
| Q3 2025 | 2025-09-30 | -0.78 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.62 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.34 | 2026-04-30 | 10-Q |
| FY 2025 | 2024-12-31 | -3.83 | 2026-03-03 | 10-K |
| Q3 2025 | 2024-09-30 | -2.34 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.31 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.31 | 2025-05-09 | 10-Q |
| FY 2025 | 2023-12-31 | -5.64 | 2026-03-03 | 10-K |
| Q3 2024 | 2023-09-30 | -1.34 | 2024-11-04 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.89 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.71 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -1.02 | 2025-03-17 | 10-K |
| Q3 2023 | 2022-09-30 | -0.68 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.40 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.20 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | 0.28 | 2024-03-15 | 10-K |
| Q3 2022 | 2021-09-30 | 0.68 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.64 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.